Formulation Development
Bio-Rad Launches PTC Tempo 96 & PTC Tempo Deepwell Thermal Cyclers
Bio-Rad Laboratories, Inc. recently announced the launch of its PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers, designed to optimize PCR applications, such as…
Woodstock Sterile Solutions Completes Analytical Lab Expansion, Becomes One-Stop Shop CDMO
Woodstock Sterile Solutions has recently completed an expansion of its quality control analytical laboratory at its production facility in Woodstock, IL. The larger laboratory accommodates…
Scorpius BioManufacturing Announces the Appointment of Gary Welch as Interim President
[caption id="attachment_137699" align="alignleft" width="150"] Gary Welch[/caption] Scorpius BioManufacturing recently announced the appointment of Gary Welch as Interim President. With a career spanning more than 30…
Stevanato Group Collaborates With Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market
The companies will offer an integrated device and fill-and-finish solution to streamline the management of the pharmaceutical supply chain….
Pharmaceutics International, Inc. Onboards New Leadership Team to Drive Quality, Operational Improvements & Growth
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO), recently announced the formation of a new leadership team whose strengths and dedication to…
Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of Investigational Anti-PCSK9 Vaccine to Treat Hypercholesterolemia
Vaxxinity, Inc. recently announced the first subjects have been dosed in a randomized, double-blind, placebo-controlled Phase 1 clinical trial of VXX-401, an investigational vaccine designed to lower low-density lipoprotein….
Allarity Therapeutics Doses First Patient in Phase 1b Clinical Trial Evaluating Dovitinib & Stenoparib Combination in Advanced Solid Tumors
Allarity Therapeutics, Inc. recently announced it has dosed the first patient in a Phase 1b clinical study evaluating the combination of stenoparib and dovitinib for…
Hovione & Ripple Enter Strategic Partnership to Expand Epidel Platform Into Non-Ophthalmic Space
Hovione and Ripple Therapeutics have entered a strategic partnership to expand the use of Ripple’s Epidel® platform beyond ophthalmic applications….
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) Annual Meeting
Synlogic, Inc. recently announced positive data from the company’s Phase 2 Synpheny-1 study for phenylketonuria (PKU) were presented in a podium presentation yesterday during the…
Enlivex Receives Positive DSMB Recommendation & IMOH Clearance to Continue Phase 1/2 Trial
Enlivex Therapeutics Ltd. recently announced an independent Data and Safety Monitoring Board (DSMB) has completed an interim data review for the first cohort of patients…
Bhami Research Laboratory & Catalent Enter Licensing Agreement for Technology to Deliver High-Concentration Biologics Subcutaneously
Bhami Research Laboratory (BRL) and Catalent recently announced a licensing agreement that will provide Catalent with access to BRL’s formulation technology to help enable the…
Catalent & Grünenthal Announce Successful Collaboration to Facilitate Expedited Clinical Development Timelines
Catalent and Grünenthal recently announced their successful formulation design and clinical-phase manufacturing collaboration for an orally dosed small molecule in Grünenthal's pipeline. Positive preclinical results…
Owlstone Medical Enters Partnership With Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, recently announced it has entered into a Research Agreement with Bicycle Therapeutics plc, a biotechnology company pioneering a new….
Roivant Reports Positive Topline Results From Phase 3 Trial of VTAMA (tapinarof) Cream, 1% Once Daily in Adults & Children as Young as 2
Dermavant Sciences, a Roivant Sciences (Nasdaq: ROIV) company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, recently announced positive results from ADORING 2, one…
Pfizer Invests $43 Billion in Seagen Acquisition to Battle Cancer
Pfizer Inc. and Seagen Inc. recently announced they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops, and commercializes transformative cancer medicines, for $229 in cash….
Nemera & Nelson Labs Europe Strengthen Partnership to Offer Integrated Services to Customers
This strategic alliance will give a unique advantage to pharmaceutical & bio-tech customers – accelerating the go-to-market of their drug-device combination products by offering analytical chemistry, drug compatibility lab testing and expert advice….
Ajinomoto Bio-Pharma Services Awarded Three CDMO Leadership Awards
Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, received three CDMO Leadership Awards in the categories Capabilities, Compatibility, and Expertise…
Immutep Announces Initiation of Phase 2/3 Trial for Eftilagimod Alpha Plus Paclitaxel in Metastatic Breast Cancer
Immutep Limited recently announced the initiation of AIPAC-003 (Active Immunotherapy, Eftilagimod Alpha, and PAClitaxel), an integrated Phase 2/3 trial to evaluate eftilagimod alpha (efti) in combination…
Proteovant Therapeutics to Present Preclinical Data From Estrogen Receptor & IKZF2 Protein Degrader Programs
Proteovant Therapeutics, a Roivant Sciences (Nasdaq: ROIV) company leveraging the process of protein degradation to discover and develop transformative medicines for the treatment of patients…
Pii Announces New Vice President of Sales
Pharmaceutics International, Inc. (Pii) recently announced John Phillips has joined the company as Vice President of Sales. Mr. Phillips brings a wealth of almost 30…
